natgillin/translations-raw huggingface dataset:
The Terrosa Pen has a service life of two years. 
Terrosa Pen ima življenjsko dobo dveh let.
Wash your hands carefully with soap to minimise the risk of infection. 
Pazljivo si umijte roke z milom, da zmanjšate tveganje za okužbo.
• loss of energy 
• izguba energije
If no drops emerge, repeat step G until you see some drops. 
Če se kapljice ne pojavijo, ponovite korak G, dokler ne vidite nekaj kapljic.
Never share your pen with others. 
Svojega peresnika nikoli ne delite z drugimi.
Otherwise tell your doctor. 
V nasprotnem primeru obvestite svojega zdravnika.
Needles and used cartridges must be disposed of separately and safely. 
Igle in uporabljene vložke je treba odstraniti ločeno in varno.
No medicine comes out of the needle during pen preparation step “G: Priming”. 
Nič zdravila ne pride iz igle med pripravo zdravila pri koraku “G: Priprava”.
Warning: Ensure the use of the correct drug liquid. 
Opozorilo: Zagotovite uporabo pravilne tekočine z zdravilom.
Terrosa can be given with or without food. 
Zdravilo Terrosa se lahko daje s hrano ali brez nje.
The Terrosa Pen can be disposed of according to the instructions of the local authorities. 
Terrosa Pen lahko odstranite v skladu z navodili lokalnih organov.
No differences in teriparatide pharmacokinetics were detected with regard to age (range 31 to 85 years). 
V farmakokinetiki teriparatida niso zaznali razlik glede na starost (razpon od 31 do 85 let).
This is important, because some medicines (e.g. digoxin/digitalis, a medicine used to treat heart disease) may interact with teriparatide. 
To je pomembno zato, ker lahko nekatera zdravila (npr. digoksin/digitalis, zdravilo za zdravljenje bolezni srca) medsebojno delujejo s teriparatidom.
4.7 Effects on ability to drive and use machines Teriparatide has no or negligible influence on the ability to drive and use machines. 
4.7 Vpliv na sposobnost vožnje in upravljanja strojev Zdravilo Teriparatid nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
Your doctor will advise you and decide how long you should be treated with Terrosa. 
Vaš zdravnik vam bo svetoval in se odločil, kako dolgo se morate zdraviti z zdravilom Terrosa.
• other cases of exposure and wear, not in accordance with the instructions for use. 
• drugi primeri izpostavljenosti in obrabe, ki niso v skladu z navodili za uporabo.
A small air bubble will not affect the dose, or harm. 
Majhen zračni mehurček ne vpliva na odmerek ali škoduje.
• Select an appropriate injection site and prepare your skin as recommended by your doctor. 
• Izberite primerno mesto injiciranja in kožo pripravite tako, kot vam je priporočil vaš zdravnik.
Do not use alcohol, other solvents or cleaning agents. 
Ne uporabljajte alkohola, drugih topil ali čistilnih sredstev.
Colourless, clear solution for injection with a pH of 3.8 - 4.5. 
Brezbarvna, bistra raztopina za injiciranje s pH 3,8-4,5.
If the instructions are not followed, there are risks of incorrect medication, inaccurate dosage, disease transmission or infection. 
Če ne sledite navodilom, obstaja tveganje nepravilnega zdravljenja, netočnega odmerjanja, prenosa bolezni ali okužbe.
• if you are allergic to teriparatide or any of the other ingredients of this medicine (listed in section 6). 
• če ste alergični na teriparatid ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
Follow the instructions presented in this instructions for use. 
Upoštevajte navodila v teh navodilih za uporabo.
This study included postmenopausal women (N=277), premenopausal women (N=67), and men (N=83). 
Ta študija je vključevala ženske po menopavzi (N = 277), ženske pred menopavzo (N = 67) in moške (N = 83).
Local, healthcare professional or institutional policies may replace the instructions regarding needle handling and disposal. 
Lokalne, zdravstvene ali institucionalne smernice lahko nadomestijo navodila za ravnanje z iglami in njihovo odstranjevanje.
B: Remove the cartridge holder by turning it (bayonet coupling). 
B: Odstranite nosilec vložka tako, da ga obračate (bajonetni spoj).
Do not press the push button. 
Ne pritiskajte na gumb.
Set the dose and complete the injection as described in section “2. 
Nastavite odmerek in dokončajte injiciranje, kot je opisano v poglavju "2.
G: Priming 
G: Priprava
The Terrosa Pen must not be used by blind or visually impaired patients without help from a trained able-bodied person. 
Terrosa Pen ne smejo uporabljati slepi ali slabovidni bolniki brez pomoči usposobljene osebe.
• use contrary to the instructions for use 
• uporaba v nasprotju z navodili za uporabo
• if you have ever had bone cancer or if other cancers have spread (metastasised) to your bones. 
• če ste že kdaj imeli kostnega raka ali če so se druge oblike raka razširile (metastazirale) v vaše kosti.
The pivotal study included 1,637 postmenopausal women (mean age 69.5 years). 
Ključna študija je vključevala 1637 žensk po menopavzi (povprečna starost 69,5 let).
• if you have unexplained high levels of alkaline phosphatase in your blood, which means you might have Paget's disease of bone (disease with abnormal bone changes). 
• če imate nepojasnjene visoke ravni alkalne fosfataze v krvi, kar pomeni, da imate morda Pagetovo bolezen kosti (bolezen z abnormalno spremembo kosti).
It is limited to replacement of the pen. 
To je omejeno na zamenjavo peresnika.
The warranty covers manufacturing and material defects of your Terrosa Pen for two years of use, from purchase. 
Garancija Garancija zajema napake pri izdelavi in materialne napake vašega Terrosa Pen za dve leti uporabe, od nakupa.
Consult your doctor in the case of hearing or handling problems. 
Posvetujte se s svojim zdravnikom v primeru težav s sluhom ali težavah z rokovanjem.
- Pregnancy and breast-feeding (see sections 4.4 and 4.6). 
- Nosečnost in dojenje (glejte poglavji 4.4 in 4.6).
Check if the display is at the start position to make sure that the full dose has been injected. 
Preverite, če je zaslon v začetnem položaju, da se prepričate o injiciranju celotnega odmerka.
• Re-attach the pen cap after each use. 
• Ponovno pritrdite pokrovček za pero po vsaki uporabi.
Do not use Terrosa: 
Ne uporabljajte zdravila Terrosa:
Question 
Vprašanje
Change the needle and repeat the priming as described in pen preparation sections “F” and “G”. 
Zamenjajte iglo in ponovite pripravo, kot je opisano v poglavjih "F" in "G".
Osteoporosis is also common in patients receiving medicines called corticosteroids. 
Osteoporoza je pogosta tudi pri bolnikih, ki prejemajo zdravila, imenovana kortikosteroidi.
Fracture incidence in postmenopausal women Placebo (N = 544) (%) 
Incidenca zlomov pri ženskah po menopavzi Placebo (N = 544) (%)
• if you suffer from kidney stones or have had kidney stones. 
• če imate težave zaradi ledvičnih kamnov ali če ste imeli ledvične kamne.
Inject Terrosa each day for as long as your doctor prescribes it for you. 
Zdravilo Terrosa si vbrizgajte vsak dan, tako dolgo, kolikor vam vaš zdravnik predpiše.
- Pre-existing hypercalcaemia. 
- Že obstoječa hiperkalciemija.
While attaching the needle some drops may escape, this is normal. 
Med pritrditvijo igle lahko uide nekaj kapljic, kar je normalno.
Women of childbearing potential / Contraception in females 
Ženske, ki bi lahko zanosile/Kontracepcija za ženske
• pain in the muscles and pain in the joints. 
• bolečina v mišicah in bolečina v sklepih.
Teriparatide should be used with caution in patients with active or recent urolithiasis because of the potential to exacerbate this condition. 
Teriparatid je treba pri bolnikih z aktivno ali nedavno urolitiazo uporabljati previdno zaradi možnosti poslabšanja tega stanja.
- After your injection, leave the needle in the skin for six seconds to make sure that you receive the whole dose. 
- Po injiciranju pustite iglo v koži šest sekund, da boste zagotovili prejem celotnega odmerka.
Immediately consult the doctor if a broken needle gets stuck in the skin. 
Takoj se posvetujte z zdravnikom, če vam zlomljena igla ostane v koži.
Use another needle instead. 
Namesto te uporabite drugo iglo.
Overdose experience based on post-marketing spontaneous reports 
Izkušnje s prevelikim odmerjanjem na podlagi spontanih poročil po uvedbi zdravila na trg
Needle is broken/curved/kinked. 
Igla je pokvarjena/ukrivljena/upognjena.
The Terrosa Pen can be used by self-injecting patients above the age of 18 years, healthcare professionals or third parties such as, for instance, adult relatives. 
Terrosa Pen lahko uporabljajo za samoinjiciranje bolniki starejši od 18 let, zdravstveni delavci ali druge osebe, kot na primer odrasli sorodniki.
Broken needles can get stuck in the skin. 
Zlomljene igle lahko ostanejo v koži.
E: Attach the cartridge holder to the housing by turning it 90 degrees, until it stops. 
E: Nosilec vložka pritrdite na ohišje tako, da ga obračate za 90 stopinj, dokler se ne ustavi.
Your doctor may advise you to take Terrosa with calcium and vitamin D. Your doctor will tell you how much you should take each day. 
Vaš zdravnik vam bo morda ob uporabi zdravila Terrosa svetoval jemanje kalcija in vitamina D. Povedal vam bo tudi, kolikšen odmerek vzemite vsak dan.
Note: There is no need to change the needle when using directly after the pen preparation. 
Opomba: Igle ni treba zamenjati pri uporabi neposredno po pripravi peresnika.
d p≤0.025 compared with placebo. 
dp ≤ 0,025 v primerjavi s placebom
At baseline, 35% of patients had a vertebral fracture and 59% had a non-vertebral fracture. 
V osnovnem stanju je imelo 35 % bolnikov vretenčni zlom in 59 % nevretenčni zlom.
Do not use the pen needle if the packaging is damaged or not opened by yourself. 
Ne uporabljajte igle za peresnike, če je embalaža poškodovana ali je niste odprli sami.
• low haemoglobin or red blood cell count (anaemia). 
• nizek hemoglobin ali nizko število rdečih krvnih celic (anemija)
The half-life of teriparatide is approximately 1 hour when administered subcutaneously, which reflects the time required for absorption from the injection site. 
Razpolovni čas teriparatida je približno 1 ura po subkutanem dajanju, kar odraža čas, potreben za absorpcijo z mesta injiciranja.
Make sure that the two indicator stripes are aligned. 
Prepričajte se, da sta obe a indikatorski črti poravnani.
Each cartridge should be properly disposed of after 28 days of first use, even if it is not completely empty. 
Vložek po 28 dneh po prvi uporabi ustrezno zavrzite, tudi če ni popolnoma prazen.
Avoid placing the cartridge close to the ice compartment of the refrigerator to prevent freezing. 
Vložkov ne polagajte blizu zamrzovalnega dela hladilnika, da se izognete zamrznjenju.
If you have any questions concerning the use of the Terrosa Pen, contact our customer service at any time. 
Če imate kakršna koli vprašanja o uporabi Terrosa Pen, se kadar koli obrnite na našo podporo za stranke.
There is no specific antidote for teriparatide. 
Za teriparatid ni specifičnega antidota.
In a study of 15 healthy subjects administered digoxin daily to steady state, a single teriparatide dose did not alter the cardiac effect of digoxin. 
V študiji 15 zdravih oseb, ki so dnevno prejemali digoksin do stanja dinamičnega ravnovesja, enkratni odmerek teriparatida ni spremenil učinka digoksina na srce.
Never immerse the Terrosa Pen in water, as this could damage the pen. 
Nikoli ne potopite peresnika Terrosa v vodo, saj bi to lahko poškodovalo peresnik.
• if you have high levels of calcium in your blood (hypercalcaemia). 
• če imate visoke ravni kalcija v krvi (hiperkalciemija).
Elderly Dosage adjustment based on age is not required (see section 5.2). 
Starejši Prilagoditev odmerjanja glede na starost ni potrebna (glejte poglavje 5.2).
• the pen being used with a medical device, accessories or consumables other than those recommended by Gedeon Richter Plc. 
• uporaba peresnika z medicinskimi pripomočki, dodatki ali potrošnim materialom, razen tistih, ki jih priporoča Gedeon Richter Plc.
If you have discomfort around the area of the injection such as redness of the skin, pain, swelling, itching, bruising or minor bleeding (which can occur in up to 1 in 10 people), this should clear up in a few days or weeks. 
Če občutite neugodje v bližini mesta injiciranja, kot je npr. rdečica na koži, bolečina, oteklina, srbenje, podplutbo ali manjše krvavitve (pojavijo se lahko pri največ 1 od 10 bolnikov), se to navadno izboljša v nekaj dneh ali tednih.
Empty cartridges must not be refilled. 
Praznih vložkov se ne sme znova polniti.
The total duration of treatment with Terrosa should not exceed 24 months. 
Celotno trajanje zdravljenja z zdravilom Terrosa ne sme biti daljše od 24 mesecev.
Some patients have had severe back cramps or pain which led to admission into hospital. 
Pri nekaterih bolnikih je prišlo do hudih krčev v hrbtu ali bolečine, zaradi katere so bili sprejeti v bolnišnico.
However, the hyperuricaemia did not result in an increase in gout, arthralgia, or urolithiasis. 
Vendar pa hiperurikemija ni povzročila povišanja pojavnosti protina, artralgij ali urolitiaze.
The maximum total duration of treatment with teriparatide should be 24 months (see section 4.4). 
Najdaljše skupno trajanje zdravljenja s teriparatidom naj bo 24 mesecev (glejte poglavje 4.4).
Teriparatide is eliminated through hepatic and extra-hepatic clearance (approximately 62 L/hr in women and 94 L/hr in men). 
Teriparatid se izloča z jetrnim in zunaj-jetrnim očistkom (približno 62 l/h pri ženskah in 94 l/h pri moških).
- Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 
- Preobčutljivost na učinkovino ali katerokoli pomožno snov, navedeno v poglavju 6.1.
• dropping, impact, application of force, contact with fluids 
• padec, udarci, uporaba sile, stik s tekočinami
Children and adolescents Terrosa should not be used in children and adolescents (aged less than 18 years). 
Otroci in mladostniki Zdravila Terrosa se ne sme uporabljati pri otrocih in mladostnikih (mlajših od 18 let).
Do not use Terrosa if it is, or has been, frozen. 
Zdravila Terrosa ne uporabite, če je, ali če je bilo zamrznjeno.
- Unexplained elevations of alkaline phosphatase. 
- Nepojasnjene povišane vrednosti alkalne fosfataze.
Do not use your Terrosa Pen to inject any other medicine (e.g. insulin). 
Ne uporabljajte svojega peresnika Terrosa Pen za injiciranje drugih zdravil (npr. insulina).
The 24-month course of teriparatide should not be repeated over a patient's lifetime. 
24-mesečni postopek zdravljenja s teriparatidom ne sme biti ponovljen v času bolnikovega življenja.
Treatment of suspected overdose should include transitory discontinuation of teriparatide, monitoring of serum calcium, and implementation of appropriate supportive measures, such as hydration. 
Zdravljenje domnevnega prevelikega odmerjanja naj vključuje prehodno ukinitev teriparatida, spremljanje serumskih koncentracij kalcija in uporabo ustreznih podpornih ukrepov, kot je hidracija.
Insert the needle straight and gently into the skin, as shown in the illustration. 
Iglo naravnost in nežno potisnite v kožo, kot je prikazano na sliki.
Teriparatide (rhPTH(1-34)) is the active fragment (1-34) of endogenous human parathyroid hormone. 
Teriparatid (rhPTH(1-34)) je aktivni fragment (1-34) endogenega humanega paratiroidnega hormona.
In post-marketing spontaneous reports, there have been cases of medication error where the entire contents (up to 800 micrograms) of a teriparatide pen have been administered as a single dose. 
V spontanih poročilih po uvedbi zdravila na trg so poročali o primerih napačnega odmerjanja, ko so dali vso vsebino (do 800 mikrogramov) peresnika s teriparatidom kot enkratni odmerek.
All patients were offered 1000 mg calcium per day and 800 IU vitamin D per day. 
Vsem bolnikom so ponudili 1000 mg kalcija na dan in 800 i.e. vitamina D dnevno.
• Store your Terrosa Pen, cartridges and pen needles out of reach of children. 
• Shranjujte vaš Terrosa Pen, vložke in igle peresnika izven dosega otrok.
• a hernia of the tube that carries food to your stomach (hiatus hernia) 
• hernija v predelu, ki prinaša hrano v vaš želodec (hiatusna kila)
Generally, antibodies were first detected following 12 months of treatment and diminished after withdrawal of therapy. 
V splošnem so protitelesa prvič zaznali po 12 mesecih zdravljenja, po ukinitvi zdravljenja pa se je koncentracija protiteles ponovno zmanjšala.
Discard the cartridge 28 days after the first use. 
Vložek zavrzite 28 dni po prvi uporabi.
How do I reset the dose knob to the start position? 
Kako ponastavim gumb za odmerjanje v začetni položaj?
Non-vertebral fragility fractures c 
Nevretenčni zlomi zaradi krhkosti c
During dose dialling the pen provides an audible clicking sound and a noticeable resistance. 
Med izbiranjem odmerka pero proizvaja klikajoče zvoke ter opazen upor.
• nerve pain in the leg 
• bolečine živcev v nogah
Some patients get dizzy or get a fast heartbeat after the first few doses of Terrosa. 
Nekateri bolniki postanejo omotični ali imajo po prvih nekaj odmerkih zdravila Terrosa hitrejši utrip srca.
It will also stop air going back into the cartridge and the needle from clogging. 
Prav tako boste preprečili vračanje zraka v vložek in zamašitev igle.
What Terrosa is and what it is used for 
Kaj je zdravilo Terrosa in za kaj ga uporabljamo
What you need to know before you use Terrosa 
Kaj morate vedeti, preden boste uporabili zdravilo Terrosa
Results from up to 24 months (median: 19 months) treatment with teriparatide demonstrate statistically significant fracture reduction (Table 1). 
Rezultati do 24 mesecev (mediana: 19 mesecev) trajajočega zdravljenja s teriparatidom kažejo statistično značilno znižanje števila zlomov (Preglednica 1).
Teriparatide may cause small increases in urinary calcium excretion, but the incidence of hypercalciuria did not differ from that in the placebo-treated patients in clinical trials. 
Teriparatid lahko povzroči majhna povečanja izločanja kalcija s sečem, vendar se incidenca hiperkalciurije ni razlikovala od incidence pri bolnikih, ki so v kliničnih preskušanjih prejemali placebo.
D: Push back the threaded rod carefully with your finger, in a straight line and as far as it will go. 
D: Previdno potisnite navojno palico s prstom, naravnost in do konca.
In clinical trials, 2.8% of teriparatide patients had serum uric acid concentrations above the upper limit of normal compared with 0.7% of placebo patients. 
V kliničnih preskušanjih je imelo 2,8 % bolnikov, ki so prejemali teriparatid, serumske koncentracije sečne kisline nad zgornjo mejo normalnih vrednosti v primerjavi z 0,7 % bolnikov, ki so prejemali placebo.
A: Remove the pen cap. 
A: Odstranite pokrovček za pero.
There were no important effects observed in pregnant rats or mice administered teriparatide at daily doses of 30 to 1000 micrograms/kg. 
Niso opazili nobenih pomembnih učinkov pri brejih podganah ali miših, ki so jim dajali teriparatid v dnevnih odmerkih 30 do 1000 mikrogramov/kg.
Teriparatide has been evaluated in pharmacodynamic interaction studies with hydrochlorothiazide. 
Teriparatid so vrednotili v študijah farmakodinamičnega medsebojnega delovanja s hidroklorotiazidom.
Following cessation of teriparatide therapy, patients may be continued on other osteoporosis therapies. 
Po ukinitvi zdravljenja s teriparatidom lahko bolniki naprej prejemajo druga zdravila za osteoporozo.
The pen needles must be used only once and the Terrosa cartridge must be used by one person only. 
Igle za peresnike je potrebno uporabiti samo enkrat in vložek Terrosa mora uporabljati samo ena oseba.
In postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. 
Pri ženskah po menopavzi so dokazali pomembno znižanje pojavnosti vretenčnih in nevretenčnih zlomov, ne pa tudi zlomov kolka.
This helps you to know when the 28 daily doses per cartridge are used. 
Tako boste vedeli, kdaj boste uporabili 28 dnevnih odmerkov na vložek.
Troubleshooting Follow the instructions given in the table if you have any questions regarding the use of Terrosa Pen: 
Upoštevajte navodila v tabeli, če imate kakršna koli vprašanja glede uporabe Terrosa Pen:
Keep the needle in the skin fold for a further 6 seconds. 
Igle ne odstranjujte iz kožne gube še nadaljnjih 6 sekund.
You can use Terrosa for up to 28 days after the first injection, as long as the cartridge/pen with the cartridge inserted is stored in a refrigerator (2 °C to 8 °C). 
Zdravilo Terrosa lahko uporabljate do 28 dni po prvem injiciranju, če je vložek/peresnik z vstavljenim vložkom shranjen v hladilniku (pri temperaturi med 2 °C in 8 °C).
QR code to be included www.terrosapatient.com 
www.terrosapatient.com
The skeletal effects of teriparatide depend upon the pattern of systemic exposure. 
Učinki teriparatida na okostje so odvisni od načina izpostavljanja sistema.
Note for healthcare professionals 
Opomba za zdravstvene delavce
Note: If the cartridge contains less than 80 microliters, the dose knob cannot be turned clockwise up to the arrow sign. 
Opomba: Če vložek vsebuje manj kot 80 mikrolitrov, gumba za odmerjanje ni mogoče več obrniti v smeri urinega kazalca do oznake puščice.
Teriparatide has been administered in single doses of up to 100 micrograms and in repeated doses of up to 60 micrograms/day for 6 weeks. 
Teriparatid so dajali v enkratnih odmerkih do 100 mikrogramov in v večkratnih odmerkih do 60 mikrogramov dnevno 6 tednov.
Post-treatment management: Following treatment with teriparatide, 1,262 postmenopausal women from the pivotal trial enrolled in a post-treatment follow-up study. 
Obravnava po zdravljenju: Po zdravljenju s teriparatidom je 1262 žensk po menopavzi iz ključnega preskušanja sodelovalo v kontrolni študiji bolnikov po zdravljenju.
• if you suffer from kidney problems (moderate renal impairment). 
• če imate težave z ledvicami (zmerno okvaro ledvic).
• BD Micro-Fine Ultraneedles 29 to 31 gauge (diameter 0.25 - 0.33 mm) and 12.7, 8 or 5 mm length Pen needles from other manufacturers can be used according to their stated compatibility details. 
• BD Micro-Fine Ultra igle 29 do 31G (premer 0.25 - 0.33 mm) in 12.7, 8 ali 5 mm dolžine Igle za peresnike drugih proizvajalcev se lahko uporabljajo v skladu z njihovimi navedenimi podatki o združljivosti.
- Metabolic bone diseases (including hyperparathyroidism and Paget's disease of the bone) other than primary osteoporosis or glucocorticoid-induced osteoporosis. 
- Presnovne bolezni kosti (vključujoč hiperparatiroidizem in Pagetovo bolezen kosti) z izjemo primarne osteoporoze ali osteoporoze, povzročene z glukokortikoidi.
Setting the dose and injection”. 
Nastavitev odmerka ter injiciranje".
Pharmacotherapeutic group: Calcium homeostasis, parathyroid hormones and analogues, ATC code: H05AA02 
Farmakoterapevtska skupina: zdravila za uravnavanje homeostaze kalcija, obščitnični hormoni in analogi, oznaka ATC: H05AA02.
- Patients with skeletal malignancies or bone metastases should be excluded from treatment with teriparatide. 
- Bolniki s skeletnimi malignostmi ali kostnimi metastazami morajo biti izključeni iz zdravljenja s teriparatidom.
Therefore, if blood samples for serum calcium measurements are taken, this should be done at least 16 hours after the most recent teriparatide injection. 
Če se jemlje vzorec za določanje serumske koncentracije kalcija, mora biti le-ta vzet vsaj 16 ur po zadnji injekciji teriparatida.
Answer 
Odgovor
The pen must be primed and tested after inserting a new cartridge and prior the first injection from each cartridge. 
Peresnik je treba pripraviti in preizkusiti po vstavitvi novega vložka in pred prvo injekcijo iz vsakega vložka.
In an open-label study, 503 postmenopausal women with severe osteoporosis and a fragility fracture within the previous 3 years (83% had received previous osteoporosis therapy) were treated with teriparatide for up to 24 months. 
V odprti študiji je 503 žensk po menopavzi, ki so imele hudo osteoporozo in zlom zaradi krhkosti v zadnjih 3 letih (83 % jih je bilo predhodno zdravljenih za osteoporozo), do 24 mesecev dobivalo teriparatid.